Drug Trials Snapshots: POMBILITI (cipaglucosidase alfa-atga)

POMBILITI is an enzyme used for the treatment of adult patients with late-onset Pompe disease (LOPD) weighing ≥40 kg and who are not improving on their current enzyme replacement therapy. POMBILITI is approved for use in combination with Opfolda. https://www.fda.gov/drugs/development-approval-process-drugs/drug-trials-snapshots-pombiliti